Raloxifene Hydrochloride

CHEMBL1116 Phase 4 معتمد Small molecule

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

510.0 g/mol

LogP

—

Phase

4

The hydrochloride salt form of raloxifene prescribed to strengthen bones and reduce fracture risk in postmenopausal women, as well as to lower the risk of certain breast cancers. It offers the bone-protective benefits of estrogen while acting as an estrogen blocker in breast tissue.

الوزن الجزيئي

510,0000 g/mol

TPSA

98,20 Å²

المجالات العلاجية

Endometriosis Benign Prostatic Hyperplasia Rheumatoid Arthritis Osteoporosis Schizophrenia Breast Cancer Cardiovascular Disease Prostate Cancer

Pharmacokinetics (PK)

Pharmacodynamics (PD)

البنية ثنائية الأبعاد

SVG PNG

Cite this structure

Embed this structure

SMILES

Cl.O=C(c1ccc(OCCN2CCCCC2)cc1)c1c(-c2ccc(O)cc2)sc2cc(O)ccc12

InChI

InChI=1S/C28H27NO4S.ClH/c30-21-8-4-20(5-9-21)28-26(24-13-10-22(31)18-25(24)34-28)27(32)19-6-11-23(12-7-19)33-17-16-29-14-2-1-3-15-29;/h4-13,18,30-31H,1-3,14-17H2;1H

Molecular Formula

C28H28ClNO4S

HBD / HBA

3 / 6

الروابط القابلة للدوران

7

الذرات الثقيلة

35

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

الأسئلة الشائعة

The hydrochloride salt form of raloxifene prescribed to strengthen bones and reduce fracture risk in postmenopausal women, as well as to lower the risk of certain breast cancers. It offers the bone-protective benefits of estrogen while acting as an estrogen blocker in breast tissue.

Yes, Raloxifene Hydrochloride is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1116. Open-access bioactivity database.
PubChem — National Center for Biotechnology Information (NCBI). CID 54900. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

PillFYI

هل تبحث عن معلومات ملائمة للمرضى؟

Raloxifene Hydrochloride على PillFYI

البنية

بيانات سريعة

الصيغة الجزيئية: C28H28ClNO4S
المرادفات: 1

روابط خارجية

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

إخلاء المسؤولية الطبية

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.